Document Detail

Thirty-year trends in outcomes of percutaneous coronary interventions in diabetic patients.
MedLine Citation:
PMID:  23274017     Owner:  NLM     Status:  MEDLINE    
OBJECTIVE: To characterize in-hospital and long-term outcomes after percutaneous coronary interventions (PCIs) in patients with diabetes mellitus (DM).
PATIENTS AND METHODS: Patients who underwent PCIs were grouped by era: group 1, October 9, 1979, to December 31, 1989 (408 with DM and 2684 without DM); group 2, January 1, 1990, to December 31, 1996 (1170 and 4664); group 3, January 1, 1997, to December 31, 2003 (2032 and 6584); and group 4, January 1, 2004, to December 31, 2008 (1412 and 4141). The main outcome measures were in-hospital mortality, major adverse cardiovascular events, long-term mortality, composites of mortality with revascularization, and ischemic events.
RESULTS: Patients with DM had significant declines in in-hospital adverse outcomes over time. These declines were similar to those observed in patients without DM. After adjusting for baseline risk, there was no significant change in the association between DM and in-hospital death or in-hospital major adverse cardiovascular events over time. The use of aspirin, β-blockers, angiotensin-converting enzyme inhibitors, lipid-lowering drugs, and thienopyridines all increased over time. The effect of DM on long-term survival and survival free of revascularization did not change significantly from group 2 to group 4. However, the effect of DM on survival free of myocardial infarction and stroke was reduced significantly, from a hazard ratio (95% CI) of 1.71 (1.51-1.92) in group 2 to 1.39 (1.20-1.60) in group 4 (P=.04).
CONCLUSION: Over 30 years, the improving outcomes in patients with diabetes who underwent PCIs have been similar to improvements in patients without DM. However, the risk-adjusted association of DM with long-term death, myocardial infarction, and stroke has decreased in the current era (group 4) compared with the bailout stent era (group 2).
Mandeep Singh; David R Holmes; Bernard J Gersh; Robert L Frye; Ryan J Lennon; Charanjit S Rihal
Related Documents :
8993957 - Thalidomide and recurrent aphthous stomatitis: a follow-up study.
23882877 - Prognostic value of elevated mean platelet volume in patients undergoing primary angiop...
16539817 - Modification of neutrophil function by plasma of rheumatoid arthritis patients treated ...
24903847 - Pancreaticogastrostomy versus pancreaticojejunostomy after pancreaticoduodenectomy: a s...
22134627 - A randomized controlled trial comparing mupirocin and polysporin triple ointments in pe...
20120667 - Total knee replacement following repeated cycles of intra-articular sodium hyaluronate ...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Mayo Clinic proceedings     Volume:  88     ISSN:  1942-5546     ISO Abbreviation:  Mayo Clin. Proc.     Publication Date:  2013 Jan 
Date Detail:
Created Date:  2012-12-31     Completed Date:  2013-03-12     Revised Date:  2013-12-13    
Medline Journal Info:
Nlm Unique ID:  0405543     Medline TA:  Mayo Clin Proc     Country:  England    
Other Details:
Languages:  eng     Pagination:  22-30     Citation Subset:  AIM; IM    
Copyright Information:
Copyright © 2013 Mayo Foundation for Medical Education and Research. Published by Elsevier Inc. All rights reserved.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Angioplasty, Balloon, Coronary
Cardiovascular Agents / therapeutic use
Coronary Angiography
Coronary Artery Disease / mortality,  therapy*
Diabetes Complications / mortality,  therapy*
Hospital Mortality
Logistic Models
Middle Aged
Percutaneous Coronary Intervention / methods*,  mortality
Proportional Hazards Models
Risk Factors
Survival Rate
Treatment Outcome
Reg. No./Substance:
0/Cardiovascular Agents

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Effect of physical activity and sedentary behavior on serum prostate-specific antigen concentrations...
Next Document:  Effect of country of origin, age, and body mass index on prevalence of vitamin D deficiency in a US ...